Gimble, J.M., S. Zvonic, Z.E. Floyd, M. Kassem, and M.E. Nuttall. 2006. Playing with bone and fat. Journal of cellular biochemistry 98 (2): 251–266.

Article  CAS  PubMed  Google Scholar 

Chen, Q., P. Shou, C. Zheng, M. Jiang, G. Cao, Q. Yang, J. Cao, N. Xie, T. Velletri, X. Zhang, C. Xu, L. Zhang, H. Yang, J. Hou, Y. Wang, and Y. Shi. 2016. Fate decision of mesenchymal stem cells: Adipocytes or osteoblasts? Cell death and differentiation 23 (7): 1128–1139.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu, L., C. Yin, F. Zhao, A. Ali, J. Ma, and A, Qian. 2018. Mesenchymal stem cells: Cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment. International journal of molecular sciences 19 (2).

Liu, S., Y. Li, L. Xia, H. Shen, and J. Lu. 2019. IL-35 prevent bone loss through promotion of bone formation and angiogenesis in rheumatoid arthritis. Clinical and experimental rheumatology 37 (5): 820–825.

PubMed  Google Scholar 

Kamiya, Y., T. Kikuchi, H. Goto, I. Okabe, Y. Takayanagi, Y. Suzuki, N. Sawada, T. Okabe, Y. Suzuki, S. Kondo, J.I. Hayashi, and A. Mitani. 2020. IL-35 and RANKL synergistically induce osteoclastogenesis in RAW264 mouse monocytic cells. International journal of molecular sciences 21 (6).

Peng, M., L. Qiang, Y. Xu, C. Li, T. Li, and J. Wang. 2019. IL-35 ameliorates collagen-induced arthritis by promoting TNF-α-induced apoptosis of synovial fibroblasts and stimulating M2 macrophages polarization. The FEBS journal 286 (10): 1972–1985.

Article  CAS  PubMed  Google Scholar 

Wu, S., Y. Li, Y. Li, L. Yao, T. Lin, S. Jiang, H. Shen, L. Xia, and J. Lu. 2016. Interleukin-35 attenuates collagen-induced arthritis through suppression of vascular endothelial growth factor and its receptors. International immunopharmacology 34: 71–77.

Article  CAS  PubMed  Google Scholar 

Liu, J.Q., Z. Liu, X. Zhang, Y. Shi, F. Talebian, J.W. Carl Jr., C. Yu, F.D. Shi, C.C. Whitacre, J. Trgovcich, and X.F. Bai. 2012. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. The Journal of Immunology 188 (7): 3099–3106.

Article  CAS  PubMed  Google Scholar 

Collison, L.W., V. Chaturvedi, A.L. Henderson, P.R. Giacomin, C. Guy, J. Bankoti, D. Finkelstein, K. Forbes, C.J. Workman, S.A. Brown, J.E. Rehg, M.L. Jones, H.T. Ni, D. Artis, M.J. Turk, and D.A. Vignali. 2010. IL-35-mediated induction of a potent regulatory T cell population. Nature immunology 11 (12): 1093–1101.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, Y., L. Yuan, S. Jiang, S. Liu, L. Xia, H. Shen, and J. Lu. 2019. Interleukin-35 stimulates tumor necrosis factor-α activated osteoblasts differentiation through Wnt/β-catenin signaling pathway in rheumatoid arthritis. International immunopharmacology 75: 105810.

Article  CAS  PubMed  Google Scholar 

Long, J., H. Guo, S. Cui, H. Zhang, X. Liu, D. Li, Z. Han, L. Xi, W. Kou, J. Xu, T.S. Li, and Y. Ding. 2016. IL-35 expression in hepatocellular carcinoma cells is associated with tumor progression. Oncotarget 7 (29): 45678–45686.

Article  PubMed  PubMed Central  Google Scholar 

Wetzel, A., B. Scholtka, F. Schumacher, H. Rawel, B. Geisendörfer, and B. Kleuser. 2021. Epigenetic DNA Methylation of EBI3 modulates human interleukin-35 formation via NFkB signaling: A promising therapeutic option in ulcerative colitis. International journal of molecular sciences, 22 (10).

Zhang, T., J. Nie, X. Liu, Z. Han, N. Ding, K. Gai, Y. Liu, L. Chen, and C. Guo. 2021. Correlation analysis among the level of IL-35, microvessel density, lymphatic vessel density, and prognosis in non-small cell lung cancer. Clinical and translational science 14 (1): 389–394.

Article  CAS  PubMed  Google Scholar 

Kam, N.W., D. Liu, Z. Cai, W.Y. Mak, C.K. Wong, K.H. Chiu, K.Y. Wong, W.L. Tsang, and L.S. Tam. 2018. Synoviocytes-derived interleukin 35 potentiates B cell response in patients with osteoarthritis and rheumatoid arthritis. The Journal of rheumatology 45 (4): 563–573.

Article  CAS  PubMed  Google Scholar 

Li, Y., L. Yao, S. Liu, W. Jisheng, L. Xia, H. Shen, and J. Lu. 2019. Correlation between serum IL-35 levels and bone loss in postmenopausal women with rheumatoid arthritis. Mediators of Inflammation 9139145.

Han, Y., C. Yu, Y. Yu, and L. Bi. 2021. CD25+ B cells produced IL-35 and alleviated local inflammation during experimental periodontitis. Oral diseases.

Mann, H., O. Kryštůfková, J. Zámečník, J. Háček, H. Hulejová, M. Filková, J. Vencovský, and L. Šenolt. 2021. Interleukin-35 in idiopathic inflammatory myopathies. Cytokine 137: 155350.

Article  CAS  PubMed  Google Scholar 

Zhang, X., Y. Zhou, L. Xu, W. Han, H. Chen, Y. Chen, H. Fu, S. Zhou, J. Zhao, Q. Wang, F. Feng, X. Zhu, K. Liu, and X. Huang. 2015. Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Annals of hematology 94 (5): 837–845.

Article  CAS  PubMed  Google Scholar 

Ferrara, G., F. Ivaldi, G. Mancardi, N. Kerlero de Rosbo, and A. Uccelli. 2021. Bone marrow transfer in relapsing-remitting EAE ameliorates disease at first remission, with no synergistic effect upon co-transplantation with mesenchymal stem cells. Vaccines 9 (7).

Shi, Y., L. Du, L. Lin, and Y. Wang. 2017. Tumour-associated mesenchymal stem/stromal cells: Emerging therapeutic targets. Nature reviews Drug discovery 16 (1): 35–52.

Article  CAS  PubMed  Google Scholar 

Lin, G.L., and K.D. Hankenson. 2011. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. Journal of cellular biochemistry 112 (12): 3491–3501.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdallah, B.M. 2017. Marrow adipocytes inhibit the differentiation of mesenchymal stem cells into osteoblasts via suppressing BMP-signaling. Journal of biomedical science 24 (1): 11.

Article  PubMed  PubMed Central  Google Scholar 

Zhang, L., M. Liu, X. Zhou, Y. Liu, B. Jing, X. Wang, Q. Zhang, and Y. Sun. 2016. Role of osteoprotegerin (OPG) in bone marrow adipogenesis. Cellular Physiology and Biochemistry 40 (3–4): 681–692.

Article  PubMed  Google Scholar 

Tasso, R., C. Ilengo, R. Quarto, R. Cancedda, R.R. Caspi, and G. Pennesi. 2012. Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis. Investigative ophthalmology & visual science 53 (2): 786–793.

Article  CAS  Google Scholar 

Guo, H., N. Zhao, H. Gao, and X. He. 2017. Mesenchymal stem cells overexpressing interleukin-35 propagate immunosuppressive effects in mice. Scandinavian journal of immunology 86 (5): 389–395.

Article  CAS  PubMed  Google Scholar 

Arthur, A., A. Zannettino, and S. Gronthos. 2009. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. Journal of cellular physiology 218 (2): 237–245.

Article  CAS  PubMed  Google Scholar 

Burkhardt, R., G. Kettner, W. Böhm, M. Schmidmeier, R. Schlag, B. Frisch, B. Mallmann, W. Eisenmenger, and T. Gilg. 1987. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study. Bone 8 (3): 157–164.

Article  CAS  PubMed  Google Scholar 

Moldes, M., Y. Zuo, R.F. Morrison, D. Silva, B.H. Park, J. Liu, and S.R. Farmer. 2003. Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. The Biochemical journal 376 (Pt 3): 607–613.

Article  CAS  PubMed  PubMed Central  Google Scholar